• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Evidence of natural selection and dominance of SARS-CoV-2 variant Lambda (C.37) over variants of concern in Cusco, Peru - Springer Nature

Mary Wilson

Well-known member
2023 Feb 14

doi: 10.1007/s00705-022-05645-x.

Maria Antonieta Quispe-Ricalde[SUP] #[/SUP][SUP] 1[/SUP], Hugo G Castelán-Sánchez[SUP] #[/SUP][SUP] 2[/SUP], Pablo M Meza-Rodríguez[SUP] 3[/SUP], Sonia Dávila-Ramos[SUP] 3[/SUP], José Luis Sierra[SUP] 4[/SUP], Ramón Batista-Garcia[SUP] 3[/SUP], Fátima Concha-Velasco[SUP] 5 6[/SUP], Sonia Flores Lucana[SUP] 5[/SUP], José De Santa Cruz[SUP] 5[/SUP], Víctor Zea[SUP] 5[/SUP], Marco Galarza[SUP] 7[/SUP], Omar Caceres-Rey[SUP] 7[/SUP], Pablo Tsukayama[SUP] 8 9 10[/SUP], Pilar Foronda[SUP] 11[/SUP], Brandon Jason Soto-Chambi[SUP] 12[/SUP], Nestor Abreu[SUP] 13 14[/SUP]

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage C.37 (Lambda) has spread rapidly in Peru and other Latin American countries. However, most studies in Peru have focused on Lima, the capital city, without knowing the dynamics of the spread of the variant in other departments. Cusco, Peru, is one of the most popular departments in the country for tourists, so the introduction of new variants of SARS-CoV-2 might occur despite closure of the borders. Therefore, in this work, we analyzed the variants circulating in Cusco. The aim of this work was to better understand the distribution of SARS-CoV-2 lineages circulating in Cusco and to characterize the genomes of these strains. To this end, 46 SARS-CoV-2 genomes from vaccinated and unvaccinated patients were sequenced in the first half of 2021. The genomes were analyzed using phylogenetic and natural selection methods. Phylogenetic trees from Cusco showed dominance of the Lambda lineage over the variants of concern (VOCs), and there was no clustering of variants by district. Natural selection analysis revealed mutations, mainly in the spike protein, at positions 75, 246, 247, 707, 769, and 1020. In addition, we found that unvaccinated patients accumulated more new mutations than did vaccinated patients, and these included the F101Y mutation in ORF7a, E419A in NSP3, a deletion in S (21,618-22,501), and a deletion in ORF3a (25,437-26,122).

https://link.springer.com/article/10.1007/s00705-022-05645-x
 
Back
Top Bottom